Latest News

GEMOXEL Regimen May Be Better Than Standard Therapy for Pancreatic Cancer

GEMOXEL Regimen May Be Better Than Standard Therapy for Pancreatic Cancer

GEMOXEL (gemcitabine, oxaliplatin, capecitabine) regimen may be safe, more efficient than standard therapy for metastatic pancreatic cancer.

Gemcitabine Plus S-1 May Be Safe, Effective for Biliary Tract Cancer

Gemcitabine Plus S-1 May Be Safe, Effective for Biliary Tract Cancer

Gemcitabine and S-1 combination chemotherapy may be an alternative therapeutic strategy in metastatic biliary tract cancer.

Pseudomonas Preparation May Improve Response Rate in Lung Cancer

Pseudomonas Preparation May Improve Response Rate in Lung Cancer

Pseudomonas aeruginosa preparation (PAP) with chemotherapy may improve response rate in patients with non-small cell lung cancer (NSCLC).

In Prostate Cancer, Androgen Deprivation Therapy Impacts Function

In Prostate Cancer, Androgen Deprivation Therapy Impacts Function

For patients with prostate cancer, androgen deprivation therapy (ADT) has a lasting impact on physical function

Over Past Decade, Small Decline in Cancer Rate in U.S.

Over Past Decade, Small Decline in Cancer Rate in U.S.

America is making slow but steady progress against cancer, with a continuing decline in cancer deaths.

Zytiga Label Update Approved

Zytiga Label Update Approved

The FDA has approved a label update for Zytiga (abiraterone acetate) plus prednisone based on final analysis of the COU-AA-302 trial.

Adjuvant Chemo Not Effective after Preoperative Chemo-Radiation, TME for Rectal Cancer

Adjuvant Chemo Not Effective after Preoperative Chemo-Radiation, TME for Rectal Cancer

No benefit from adjuvant chemotherapy with fluoropyrimidine monotherapy after preoperative (chemo)radiotherapy, TME in rectal cancer.

Low Vitamin D Levels May Be Associated with Worse Survival in Follicular Lymphoma

Low Vitamin D Levels May Be Associated with Worse Survival in Follicular Lymphoma

Low serum vitamin D levels may be associated with inferior survival in patients with follicular lymphoma.

Many Older Oncology Patients Take Multiple Medications Inappropriately

Many Older Oncology Patients Take Multiple Medications Inappropriately

A pharmacist-led assessment shows that a high number of older oncology patients use multiple, inappropriate medications.

Diabetes May Predispose Women to More Advanced Breast Cancer

Diabetes May Predispose Women to More Advanced Breast Cancer

Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer.

Bevacizumab Window Period May Be Effective for Brain Metastases of Breast Cancer

Bevacizumab Window Period May Be Effective for Brain Metastases of Breast Cancer

Administering bevacizumab before etoposide and cisplatin may be highly effective in patients with brain metastases of breast cancer.

Lenalidomide May Overcome Rituximab Resistance in B-Cell Lymphomas

Lenalidomide May Overcome Rituximab Resistance in B-Cell Lymphomas

Combination lenalidomide and rituximab overcomes prior rituximab resistance in indolent B-cell and mantle cell lymphomas.

Sunitinib May Be Acceptable First Line Treatment for Metastatic Renal Cell Carcinoma

Sunitinib May Be Acceptable First Line Treatment for Metastatic Renal Cell Carcinoma

Sunitinib represents an acceptable option in first line treatment for metastatic papillary renal cell carcinoma (mPRCC).

Minimal Benefit with Bortezomib, Dexamethasone as Maintenance Therapy for Multiple Myeloma

Minimal Benefit with Bortezomib, Dexamethasone as Maintenance Therapy for Multiple Myeloma

Addition of dexamethasone to bortezomib for the treatment of relapsed multiple myeloma as ongoing maintenance therapy has minimal benefit.

Vorinostat May Not Improve Survival in Mesothelioma

Vorinostat May Not Improve Survival in Mesothelioma

Vorinostat as second- or third-line therapy may not improve overall survival in advanced malignant pleural mesothelioma.

High Fish Intake Linked to Survival After Breast Cancer

High Fish Intake Linked to Survival After Breast Cancer

High intake of fish and long-chain ω-3 polyunsaturated fatty acids (PUFAs) is associated with reduced all-cause mortality after breast cancer.

New, Less Aggresssive Guidelines for Pancreatic Cysts

New, Less Aggresssive Guidelines for Pancreatic Cysts

New, less aggressive guidelines have been developed for management of pancreatic cysts.

Lower Lung, Colorectal Cancer Risk with High Fitness Levels in Midlife Men

Lower Lung, Colorectal Cancer Risk with High Fitness Levels in Midlife Men

Fit middle-aged men appear less likely to develop lung and colorectal cancer in later life than their out-of-shape peers.

Three Alcoholic Drinks Per Day Raises Liver Cancer Risk

Three Alcoholic Drinks Per Day Raises Liver Cancer Risk

People who have three or more alcoholic drinks per day could be raising their odds for liver cancer.

BTD Regimen May Be Viable Salvage Option for Multiple Myeloma

BTD Regimen May Be Viable Salvage Option for Multiple Myeloma

Bendamustine plus thalidomide and dexamethasone may be a viable salvage option for the treatment of double-relapsed/refractory multiple myeloma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs